Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, MK Saari - Graefe's archive for clinical and experimental …, 2002 - Springer
Background. To investigate the pharmacological basis of systemic side effects of ophthalmic
timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared …
被引用次数：165 相关文章

Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, KM Saari - Graefe's archive for clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
Background To investigate the pharmacological basis of systemic side effects of ophthalmic
timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared …

Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, KM Saari - Graefe's Archive for Clinical and …, 2002 - hero.epa.gov
Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops | Health &
Environmental Research Online (HERO) | US EPA Jump to main content US EPA United …

Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, KM Saari - Graefe's Archive for Clinical and …, 2002 - elibrary.ru
Background. To investigate the pharmacological basis of systemic side effects of ophthalmic
timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared …

Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.

JM Korte, T Kaila, KM Saari - … von Graefes Archiv fur Klinische und …, 2002 - europepmc.org
Background To investigate the pharmacological basis of systemic side effects of ophthalmic
timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared …

Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, MK Saari - Graefe's Archive for Clinical and …, 2002 - infona.pl
Background. To investigate the pharmacological basis of systemic side effects of ophthalmic
timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared …

[引用][C] Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, MK Saari - Graefe's Archive for Clinical and …, 2002 - cir.nii.ac.jp
Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, MK Saari - Graefe's Archive for Clinical and …, 2002 - search.proquest.com
Background. To investigate the pharmacological basis of systemic side effects of ophthalmic
timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared …

[引用][C] Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM KORTE, T KAILA, KM SAARI - Graefe's archive for clinical …, 2002 - pascal-francis.inist.fr
Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

[引用][C] Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

JM Korte, T Kaila, KM Saari… - Graefes Arch Clin Exp …, 2002 - researchportal.tuni.fi
Systemic bioavailability and cardiopulmonary effects of 0.5 % timolol eyedrops — Tampere
University Research Portal Skip to main navigation Skip to search Skip to main content Tampere …